2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Aspirin: new trials by email Literature Review of Aspirin trials Research Report on Aspirin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Protective Effect of Aspirin on COVID-19 Patients Aspirin 100mg - Novel Coronavirus Pneumonia, Aspirin | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 128 | 2020-02-10 | 2020-04-28 |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex Aspirin, AED, Placebo - Tuberous Sclerosis Complex, Aspirin | Phase 2 | Unknown | Peking Union Medical College Hospital | 98 | 2017-11-20 | 2020-06-09 |
Cognitive Dysfunction (1) · Epilepsy (1) · Seizures (1) · Tuberous Sclerosis (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms, Multiple Primary (1) · Neoplastic Syndromes, Hereditary (1) · Nervous System Diseases (1)
Aspirin (2) · Anticonvulsants (1) · Oxygen (1)
Peking Union Medical College Hospital (1) · Xijing Hospital (1)
China (2)
Cai Yue (1) · Qing Liu, MD PhD (1)